{{medical}}
{{Infobox medical condition (new)
| name            = 非霍奇金氏淋巴瘤
| image           = Mantle cell lymphoma - intermed mag.jpg
| caption         = [[被套細胞淋巴瘤|被套細胞淋巴瘤]]的顯微照片。被套細胞淋巴瘤是非霍奇金氏淋巴瘤的一種。 [[迴腸|迴腸]]末端，使用[[H&E染色|H&E染色]]。
| synonyms        = 
| field           = [[血液學|血液學]]和[[腫瘤學|腫瘤學]]
| symptoms        = [[淋巴結腫大|淋巴結腫大]]、發燒、{{le|夜間盗汗|night sweats}}、體重減輕、疲倦、搔癢<ref name=NCI2016AdPt/>
| complications   = 
| onset           = 65–75歲年長者<ref name=SEER2016/>
| duration        = 
| causes          = 
| risks           = [[免疫缺陷|免疫缺陷]]、[[自體免疫疾病|自體免疫疾病]]、[[幽門螺旋桿菌|幽門螺旋桿菌]]感染、[[C型肝炎|C型肝炎]]、[[肥胖|肥胖]]、{{le|人類疱疹病毒感染|Epstein–Barr virus infection}}<ref name=NCI2016AdPt/><ref name=WCR2014Cp2/>
| diagnosis       = [[骨髓|骨髓]]或[[淋巴結|淋巴結]]切片<ref name=NCI2016AdPt/>
| differential    = 
| prevention      = 
| treatment       = [[化學療法|化學療法]]、[[放射線療法|放射線療法]]、[[免疫療法|免疫療法]]、[[標靶治療|標靶治療]]、[[骨髓移植|骨髓移植]]、手術、{{le|監察式等待|watchful waiting}}<ref name=NCI2016AdPt/>
| medication      = 
| prognosis       = [[五年存活率|五年存活率]] 72% (USA)<ref name=SEER2016/>
| frequency       = 430萬人 (2015年)<!-- prevalence --><ref name=GBD2015Pre>{{cite journal|last1=GBD 2015 Disease and Injury Incidence and Prevalence|first1=Collaborators.|title=Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.|journal=Lancet|date=8 October 2016|volume=388|issue=10053|pages=1545–1602|pmid=27733282|doi=10.1016/S0140-6736(16)31678-6|pmc=5055577}}</ref>
| deaths          = 231,400 (2015)<ref name=GBD2015De>{{cite journal|last1=GBD 2015 Mortality and Causes of Death|first1=Collaborators.|title=Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.|journal=Lancet|date=8 October 2016|volume=388|issue=10053|pages=1459–1544|pmid=27733281|doi=10.1016/s0140-6736(16)31012-1|pmc=5388903}}</ref>
}}

<!-- 定義與症狀 -->
'''非霍奇金氏淋巴瘤'''（Non-Hodgkin lymphoma）簡稱NHL，是指[[霍奇金氏淋巴瘤|霍奇金氏淋巴瘤]]以外的其他[[淋巴瘤|淋巴瘤]]<ref name=NCI2016AdPt/>。其症狀包括[[淋巴結腫大|淋巴結腫大]]、發燒、{{le|盜汗|Night sweats}}、體重降輕、容易疲倦<ref name=NCI2016AdPt/>。其他症狀包括骨頭疼痛、胸痛或是癢<ref name=NCI2016AdPt/>。有些非霍奇金氏淋巴瘤發展的很慢，有些則很快<ref name=NCI2016AdPt>{{cite web|title=Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version|url=http://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq#section/all|website=NCI|accessdate=13 August 2016|date=August 3, 2016|deadurl=no|archiveurl=https://web.archive.org/web/20160816021510/http://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq#section/all|archivedate=16 August 2016|df=}}</ref>。

<!-- 成因與診斷 -->
淋巴瘤是一種發生在[[淋巴细胞|淋巴细胞]]（一種[[白血球|白血球]]）上的腫瘤<ref name="SEER2016">{{cite web|title=SEER Stat Fact Sheets: Non-Hodgkin Lymphoma|url=http://seer.cancer.gov/statfacts/html/nhl.html|accessdate=16 January 2017|date=April 2016|archiveurl=https://web.archive.org/web/20140706125600/http://www.seer.cancer.gov/statfacts/html/nhl.html|archivedate=6 July 2014|website=NCI|deadurl=no|df=}}</ref>。危險因子包括[[免疫缺陷|免疫缺陷]]、[[自體免疫性疾病|自體免疫性疾病]]、[[幽門螺桿菌|幽門螺桿菌]]感染、[[C型肝炎|C型肝炎]]、[[肥胖|肥胖]]以及{{le|人類疱疹病毒第四型感染|Epstein–Barr virus infection}}<ref name=NCI2016AdPt/><ref name=WCR2014Cp2>{{cite book|title=World Cancer Report 2014|date=2014|publisher=World Health Organization|isbn=9283204298|pages=Chapter 2.4, 2.6}}</ref>。[[世界衛生組織|世界衛生組織]]將淋巴瘤分為五大類，其中一大類是霍奇金氏淋巴瘤<ref>{{cite web|title=Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version|url=http://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq#section/all|website=NCI|accessdate=13 August 2016|date=June 1, 2016|deadurl=no|archiveurl=https://web.archive.org/web/20160812081200/http://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq#section/all|archivedate=12 August 2016|df=}}</ref>，另外的四大類可以細分為超過60種的淋巴瘤<ref>{{cite web|title=Different types of non Hodgkin lymphoma|url=http://www.cancerresearchuk.org/about-cancer/type/non-hodgkins-lymphoma/about/types/the-most-common-types-of-non-hodgkins-lymphoma|website=Cancer Research UK|accessdate=13 August 2016|deadurl=no|archiveurl=https://web.archive.org/web/20160814034909/http://www.cancerresearchuk.org/about-cancer/type/non-hodgkins-lymphoma/about/types/the-most-common-types-of-non-hodgkins-lymphoma|archivedate=14 August 2016|df=}}</ref><ref>{{cite book|last1=Bope|first1=Edward T.|last2=Kellerman|first2=Rick D.|title=Conn's Current Therapy 2016|date=2015|publisher=Elsevier Health Sciences|isbn=9780323355353|page=878|url=https://books.google.com/books?id=_x_mCgAAQBAJ&pg=PT914|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170910182735/https://books.google.com/books?id=_x_mCgAAQBAJ&pg=PT914|archivedate=2017-09-10|df=}}</ref>。淋巴瘤的診斷會透過[[骨髓檢查|骨髓檢查]]或{{le|淋巴結活檢|Lymph node biopsy}}進行<ref name=NCI2016AdPt/>。[[醫學影像|醫學影像]]有助於[[癌症分期|癌症分期]]的判斷<ref name=NCI2016AdPt/>。

<!-- 治療 -->
非何杰金氏淋巴瘤的治療會根據淋巴瘤發展的快慢以及淋巴瘤出現在一處或是多處而定。治療方式包括[[化學治療|化學治療]]、[[放射線療法|放射線療法]]、[[免疫治疗|免疫治疗]]、[[靶向治疗|靶向治疗]]、[[骨髓移植|骨髓移植]]、手術以及{{le|監察式等待|watchful waiting}}等方式<ref name=NCI2016AdPt/>。若血液中因為存在[[抗体|抗体]]而變的濃稠，可以接受[[血漿置換|血漿置換]]<ref name=NCI2016AdPt/>。不過放射線療法及一些化學治療可能會提高往後數十年內出現其他癌症、[[心臟病|心臟病]]或是神經問題的風險<ref name=NCI2016AdPt/>。

<!-- 流行病學與存活率 -->
2015年有4300萬人罹患非何杰金氏淋巴瘤，因此造成23萬1400人死亡<ref name=GBD2015Pre/><ref name=GBD2015De/> 。美國約有2.1%的人在一生中曾得過非何杰金氏淋巴瘤<ref name=SEER2016/>。最常出現的年齡是在65歲至75歲之間<ref name=SEER2016/>。美國非何杰金氏淋巴瘤的[[五年存活率|五年存活率]]為72%<ref>{{Cite web|title=Non-Hodgkin Lymphoma - Cancer Stat Facts|url=https://seer.cancer.gov/statfacts/html/nhl.html|accessdate=2020-02-04|work=SEER|language=en|archive-date=2019-04-01|archive-url=https://web.archive.org/web/20190401204631/https://seer.cancer.gov/statfacts/html/nhl.html|dead-url=no}}</ref>。

== 命名由来 ==
[[霍奇金氏淋巴瘤|霍奇金氏淋巴瘤]]（H, Hodgkin disease），在1832年由英國醫師[[托马斯·霍奇金|托马斯·霍奇金]]（Thomas Hodgkin）首次描述。这也是人类首次描述[[淋巴癌|淋巴癌]]。其他类型[[淋巴癌|淋巴癌]]以后被陆续发现。由于霍奇金氏淋巴瘤对[[放疗|放疗]]比较敏感，有必要把它们分成一类，然后细分。关于所有霍奇金氏淋巴瘤的归类完成后，还是有很多彼此极不相同的淋巴癌等待分类。

这些剩余的非霍奇金氏淋巴瘤终于在1982年归为16种。 这16类的分类原则主要是症状缓急程度，而不见得是[[病理|病理]]上的联系。所以，这种分类对于治疗只有有限的帮助。

2008年后，[[世界卫生组织|世界卫生组织]]几乎放弃了将霍奇金氏淋巴瘤和非霍奇金氏淋巴瘤对立起来的分类法，而是将80多类淋巴癌分为4个大类<ref>{{cite book |author= ed. by Steven H Swerdlow et al. |title=WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues |publisher=Oxford Univ Pr |location= |year= 2008|pages= |isbn=978-92-8322431-0|oclc= |doi=}}</ref>。

==參考資料==
{{Reflist|2}}

==外部連結==
{{Medical condition classification and resources
| DiseasesDB     = 9065
| ICD10          = {{ICD10|C|82||c|81}}-{{ICD10|C|85||c|81}}
| ICD9           = {{ICD9|200}}, {{ICD9|202}}
| ICDO           = 9591/3
| OMIM           = 605027
| MedlinePlus    = 000581
| eMedicineSubj  = med
| eMedicineTopic = 1363
| eMedicine_mult = {{eMedicine2|ped|1343}}
| MeshID         = D008228
}}
* [http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=32 Non-Hodgkin Lymphoma] {{Wayback|url=http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=32 |date=20100627043835 }} at [[American_Cancer_Society|American Cancer Society]]
* [http://www.cancer.net/patient/Cancer+Types/Lymphoma+-+Non-Hodgkin?sectionTitle=Overview Non-Hodgkins Lymphoma] {{Wayback|url=http://www.cancer.net/patient/Cancer+Types/Lymphoma+-+Non-Hodgkin?sectionTitle=Overview |date=20120224001820 }} from Cancer.net ([[American_Society_of_Clinical_Oncology|American Society of Clinical Oncology]])
*[https://web.archive.org/web/20140103222659/http://www.lymphomas.org.uk/information-and-support/information-about-lymphoma/frequently-asked-questions#What%20is%20non-Hodgkin%20lymphoma? Patient information on non-Hodgkin lymphoma] from The Lymphoma Association
* [http://www.lymphomas.org.uk Lymphoma Association – Specialist UK charity providing free information and support to patients, their families, friends and carers]

{{恶性淋巴瘤}}

[[Category:已淘汰醫學術語|Category:已淘汰醫學術語]]
[[Category:淋巴瘤|Category:淋巴瘤]]